MAPS is also the abbreviation for The Multidisciplinary Association for Psychedelic Studies.
These folx are working to change thr course of the war on drugs
and make psychedelics and marijuana legetimate medical resources.
They are a membership-based non-profit research and educational organization. They assist scientists to design, obtain approval for, fund, conduct and report on research into the healing and spiritual potentials of psychedelics
Their journal MAPS is one of the best published magazines on the subject of psychedelics and their legitamet uses.
Since 1995, MAPS has disbursed over a million dollars to worthy research and educational projects:
Opened an FDA Drug Master File
. This is required before any drug can be researched in FDA
-approved human studies.
Assisted Dr. Charles Grob
to design, obtain approval for and fund the first FDA-approved study in the U.S. to administer MDMA to humans.
Assisted in the design and is funding the world's first government-approved scientific study of the therapeutic use of MDMA (Spain
Sponsored the first studies to analyze the purity and potency of street samples of "Ecstasy
" and medical marijuana
Funded the successful efforts of Dr. Donald Abrams
to obtain approval for the first human study in 15 years into the therapeutic use of marijuana
, along with a $1 million grant from the National Institute on Drug Abuse
Obtained Orphan Drug
designation from the FDA for smoked marijuana in the treatment of AIDS Wasting Syndrome
Funded the synthesis of psilocybin
for the first FDA-approved study in twenty-five years to evaluate psilocybin in a patient population.
Supported long-term follow-up studies of pioneering research with LSD
and psilocybin originally conducted in the 1950s
for more info see: www.maps.org